Pages that link to "Item:Q1758078"

The following pages link to A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy (Q1758078):

Displaying 35 items.

• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q305603) (← links)
• A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy (Q309128) (← links)
• A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications (Q669039) (← links)
• Combination therapies and intra-tumoral competition: insights from mathematical modeling (Q1642492) (← links)
• Ultimate dynamics of the Kirschner-Panetta model: tumor eradication and related problems (Q1681376) (← links)
• A mathematical model of treatment of cancer stem cells with immunotherapy (Q1684540) (← links)
• Optimization of combination therapy for chronic myeloid leukemia with dosing constraints (Q1789085) (← links)
• Dependence of CD8 T cell response upon antigen load during primary infection. (Q2002124) (← links)
• Modeling the stem cell hypothesis: investigating the effects of cancer stem cells and TGF \(- \beta\) on tumor growth (Q2045522) (← links)
• Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling (Q2068758) (← links)
• Analysis of stochastic dynamics of tumor with drug interventions (Q2098727) (← links)
• Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative (Q2116142) (← links)
• Mathematical modeling of tumor and cancer stem cells treated with CAR-T therapy and inhibition of TGF-\(\beta\) (Q2127659) (← links)
• Is the Allee effect relevant in cancer evolution and therapy? (Q2132320) (← links)
• Existence of periodic solution for a tumor growth model with vaccine interaction (Q2179271) (← links)
• Mathematical modelling of the inhibitory role of regulatory T cells in tumor immune response (Q2205364) (← links)
• A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q2206325) (← links)
• A minimal model of T cell avidity may identify subtherapeutic vaccine schedules (Q2240254) (← links)
• Optimal control of variable-order fractional model for delay cancer treatments (Q2245845) (← links)
• Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions (Q2283759) (← links)
• Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells (Q2288459) (← links)
• Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions (Q2328483) (← links)
• Dynamics of breast cancer under different rates of chemoradiotherapy (Q2332552) (← links)
• A mathematical model for pancreatic cancer growth and treatments (Q2632820) (← links)
• An optimal control problem of immuno-chemotherapy in presence of gene therapy (Q2671158) (← links)
• Therapy strategy in tumour cells and immune system interaction mathematical model (Q2825318) (← links)
• A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS (Q2977597) (← links)
• Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control (Q3300901) (← links)
• MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS (Q3390818) (← links)
• Efficiency of cancer treatments: <i>in silico experiments</i> (Q5001273) (← links)
• Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics (Q5216251) (← links)
• A tumor-Immune interaction model with the effect of impulse therapy (Q6058689) (← links)
• Modeling the role of immune cell conversion in the tumor-immune microenvironment (Q6077316) (← links)
• Understanding the interplay of CAR-NK cells and triple-negative breast cancer: insights from computational modeling (Q6153646) (← links)
• Mathematical analysis on a diffusion model describing the compatibility between two types of tumor cells (Q6183136) (← links)